Login / Signup

Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts.

Gaia CalameraLise Román MoltzauFinn Olav LevyKjetil Wessel Andressen
Published in: International journal of molecular sciences (2022)
Cardiac contractility is regulated by several neural, hormonal, paracrine, and autocrine factors. Amongst these, signaling through β-adrenergic and serotonin receptors generates the second messenger cyclic AMP (cAMP), whereas activation of natriuretic peptide receptors and soluble guanylyl cyclases generates cyclic GMP (cGMP). Both cyclic nucleotides regulate cardiac contractility through several mechanisms. Phosphodiesterases (PDEs) are enzymes that degrade cAMP and cGMP and therefore determine the dynamics of their downstream effects. In addition, the intracellular localization of the different PDEs may contribute to regulation of compartmented signaling of cAMP and cGMP. In this review, we will focus on the role of PDEs in regulating contractility and evaluate changes in heart failure.
Keyphrases
  • protein kinase
  • nitric oxide
  • left ventricular
  • heart failure
  • smooth muscle
  • binding protein
  • type diabetes
  • adipose tissue
  • cystic fibrosis
  • insulin resistance
  • candida albicans